Lv2
194 积分 2025-11-28 加入
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial
13天前
已关闭
Tumor necrosis factor alpha inhibitors in Behçet’s disease: indications, efficacy, and safety of two widely used agents
13天前
已完结
Discovering the Secret of Diseases by Incorporated Tear Exosomes Analysis via Rapid-Isolation System: iTEARS
2个月前
已完结
Detection of Tear Components Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry for Rapid Dry Eye Diagnosis
2个月前
已完结
Evaluation of sensitivity and specificity of diagnostic criteria for Behçet’s disease in the absence of a gold standard
2个月前
已完结
Tuberculosis Exposure With Risk of Behçet Disease Among Patients With Uveitis
2个月前
已完结
Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial
2个月前
已完结
Comparative Real‐World Effectiveness of Immunomodulatory Therapies for Prevention of Uveitis Relapse in Behçet Disease
2个月前
已完结
Integrative Single‐Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics
2个月前
已完结
Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection
2个月前
已完结
皖公网安备34019202002308
